Bipolar Affective Disorder Clinical Presentation

  • Author: Stephen Soreff, MD; Chief Editor: Iqbal Ahmed, MBBS, FRCPsych (UK)   more...
 
Updated: Apr 17, 2012
 

History

Correct diagnosis of a disorder leads to proper effective treatment. Nowhere is that more relevant than in diagnosing a patient with bipolar affective disorder. Wolkenstein et al have pointed out the advantages of applying all DSM-specific criteria in order to make the correct diagnosis.[36]

The diagnosis of bipolar I (BPI) disorder requires the presence of a manic episode of at least 1 week’s duration that leads to hospitalization or other significant impairment in occupational or social functioning. The episode of mania cannot be caused by another medical illness or by substance abuse. These criteria are based on the specifications of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR).[37]

Manic episodes are characterized by at least 1 week of profound mood disturbance, characterized by elation, irritability, or expansiveness. At least 3 of the following symptoms must also be present:

  • Grandiosity
  • Diminished need for sleep
  • Excessive talking or pressured speech
  • Racing thoughts or flight of ideas
  • Clear evidence of distractibility
  • Increased level of goal-focused activity at home, at work, or sexually
  • Excessive pleasurable activities, often with painful consequences

The mood disturbance is sufficient to cause impairment at work or danger to the patient or others. The mood is not the result of substance abuse or a medical condition.

Hypomanic episodes are characterized by an elevated, expansive, or irritable mood of at least 4 days’ duration. At least 3 of the following symptoms are also present:

  • Grandiosity or inflated self-esteem
  • Diminished need for sleep
  • Pressured speech
  • Racing thoughts or flight of ideas
  • Clear evidence of distractibility
  • Psychomotor agitation at home, at work, or sexually
  • Engaging in activities with a high potential for painful consequences

The mood disturbance is observable to others. The mood is not the result of substance abuse or a medical condition.

Major depressive episodes are characterized by the following: For the same 2 weeks, the person experiences 5 or more of the following symptoms, with at least 1 of them being either a depressed mood or characterized by a loss of pleasure or interest:

  • Depressed mood
  • Markedly diminished pleasure or interest in nearly all activities
  • Significant weight loss or gain or significant loss or increase in appetite
  • Hypersomnia or insomnia
  • Psychomotor retardation or agitation
  • Loss of energy or fatigue
  • Decreased concentration ability or marked indecisiveness
  • Preoccupation with death or suicide; patient has a plan or has attempted suicide
  • The symptoms cause significant impairment and distress.
  • The mood is not the result of substance abuse or a medical condition.

Mixed episodes are characterized by the following:

  • Persons must meet both the criteria for mania and major depression; the depressive event is required to be present for 1 week only.
  • The mood disturbance results in marked disruption in social or vocation function.
  • The mood is not the result of substance abuse or a medical condition.

The mixed symptomatology is quite common in patients presenting with bipolar symptomatology. This often causes a diagnostic dilemma.[38]

Next

Physical Examination

Use the Mental Status Examination (MSE) to diagnose bipolar disorder. This section highlights the major findings for a person with bipolar disorder. Because the patient’s mental status depends on whether he or she is depressed, hypomanic, manic, or mixed, the following discussions of the various areas of the MSE include consideration of each of these particular phases

Appearance

Persons experiencing a depressed episode may demonstrate poor to no eye contact. Their clothes may be unkempt, unclean, holed, unironed, and ill-fitting. If the person has lost significant weight, the garments may fit loosely.

The personal hygiene of individuals experiencing a depressed episode reflects their low mood, as evidenced by poor grooming, lack of shaving, and lack of washing. In women, fingernails may show different layers of polish or one layer partially removed. They may not have paid attention to their hair. Men may exhibit dirty fingernails and hands. When these individuals move, their depressed affect is demonstrated. They move slowly and very little. They show psychomotor retardation. They may talk in low tones or in a depressed or monotone voice.

Persons experiencing a hypomanic episode are busy, active, and involved. They have energy and are always on the go. They are always planning and doing things. Others notice their energy levels and mood changes.

In many ways, the behavior of a patient in the manic phase is the opposite of that of a person in the depressed phase. Patients experiencing the manic phase are hyperactive and might be hypervigilant. They are restless, energized, and active. They talk and act fast. Their attire reflects the mania. Their clothes might have been put on in haste and are disorganized. Alternately, their garments are often too bright, colorful, or garish. They stand out in a crowd because their dress frequently attracts attention.

Affect/mood

In persons experiencing a depressed episode, sadness dominates the affect. These individuals feel sad, depressed, lost, vacant, and isolated. The "2 Hs"— h opeless and h elpless—often accompany their mood. When in the presence of such patients, one comes away feeling sad and down.

In persons experiencing a hypomanic episode, the mood is up, expansive, and often irritable.

In persons experiencing a manic episode, the mood is inappropriately joyous, elated, and jubilant. These individuals are euphoric. They also may demonstrate annoyance and irritability, especially if the mania has been present for a significant length of time.

Persons experiencing a mixed episode exhibit both depression and mania within a brief period (1 wk or less).

Thought content

Patients experiencing a depressed episode have thoughts that reflect their sadness. They are preoccupied with negative ideas and nihilistic concerns, and they tend to "see the glass as half empty." They are likely to focus on death and morbid persons. Many think about suicide.

Patients experiencing a hypomanic episode are optimistic, forward thinking, and have a positive attitude.

Patients experiencing a manic episode have very expansive and optimistic thinking. They may be excessively self-confident or grandiose. They often have a very rapid production of ideas and thoughts. They perceive their minds as being very active and see themselves as being highly engaging and creative. They are highly distractible and quickly shift from one person to another.

Patients experiencing a mixed episode can oscillate dramatically between depression and euphoria, and they often demonstrate marked irritability.

Perceptions

Two forms of a major depression are described, one with psychotic features and the other without. With psychosis, the patient experiences delusions and hallucinations that are either consistent or inconsistent with the mood.

In the former, the patient’s delusions of having sinned are accompanied by guilt and remorse, or the patient feels he or she is utterly worthless and should live in total deprivation and degradation; hence, the delusional content remains consistent with the depressed mood. In the latter, some patients experience delusions that are inconsistent with the depression, such as paranoia or persecutory delusions.

Patients experiencing a hypomanic episode do not experience perceptual disturbances.

Approximately three fourths of patients experiencing a manic episode have delusions. As in major depression, the delusional content is either consistent or inconsistent with the mania. Manic delusions reflect perceptions of power, prestige, position, self-worth, and glory.

Patients experiencing a mixed episode might exhibit delusions and hallucinations consistent with either depression or mania or congruent to both.

Suicide/self-destruction

Patients experiencing a depressed episode have a very high rate of suicide. They are the individuals who attempt and succeed at killing themselves. Query patients to determine if they have any thoughts of hurting themselves (suicidal ideation) and any plans to do so. The more specific the plan, the higher the danger.

As patients emerge from a period of depression, their suicide risk may increase. This may be because, as the illness remits, executive functions are improved to the point where the person is again capable of making and carrying out a plan while the subjective feeling of depression and accompanying suicidal thoughts persist.

Patients experiencing a hypomanic or manic episode have a low incidence of suicide.

In mixed episodes, the depressed phases put the patient at risk for suicide.

Homicide/violence/aggression

In patients experiencing a depressed episode, suicide generally remains the paramount issue. However, certain persons in the depths of a depression see the world as hopeless and helpless not only for themselves but also for others. Frequently, that perspective can create and lead to a homicide followed by a suicide.

As an example, a 42-year-old mother of 2 was experiencing a significant depression as part of her bipolar disorder. She believed the earth was doomed and was a terrible place to dwell. Furthermore, she thought that if she died, her children would be left in a wretched place. Because of this view, she planned to kill her 2 children and then herself. Fortunately, her family recognized the state of affairs, which led to an emergency intervention and her hospitalization.

Patients who are hypomanic frequently show evidence of irritability and aggressiveness. They can be pushy and impatient with others.

Persons experiencing a manic episode can be openly combative and aggressive. They have no patience or tolerance for others. They can be highly demanding, violently assertive, and highly irritable. The homicidal element is particularly likely to emerge if these individuals have a delusional content to their mania. They are acting out of the grandiose belief that others must obey their commands, wishes, and directives. The patient may become violent toward those "disordent" subjects. If their delusions become persecutory in nature, they may defend themselves against others in a homicidal fashion.

Persons experiencing a mixed episode may exhibit aggression, especially in the manic phases.

Judgment/insight

In persons experiencing a depressed episode, the depression clouds and dims their judgment and colors their insights. They fail to make important actions, because they are so down and preoccupied with their own plight. They see no tomorrow; therefore, planning for it is difficult. Frequently, persons in the middle of a depression have done things such as forgetting to pay their income taxes. At that time, they have little insight into their behavior. Often, others have to persuade them to seek therapy because of their lack of insight.

Persons experiencing a hypomanic episode generally have good but expansive judgment. They may take on too many tasks or become overinvolved. Often, their distractibility impairs their judgment, and they have little insight into their driven qualities. They see themselves as productive and conscientious, not as hypomanic.

In patients experiencing a manic episode, judgment is seriously impaired. These persons make terrible decisions in their work and family. They may invest the family fortune in very questionable programs, become professionally overinvolved in work activities or with coworkers, or start dramatically unsound fiscal or professional ventures. They ignore feedback, suggestions, and advice from friends, family, and colleagues. They have no insight into the extreme nature of their demands, plans, and behavior. Often, commitment proves the only way to contain them.

In persons experiencing a mixed episode, major shifts in affect during short lengths of time severely impair their judgment and interfere with their insight.

Cognition

Impairments in orientation and memory are seldom observed in patients with bipolar disorder unless they are very psychotic. They know the time and their location, and they recognize people. They can remember immediate, recent, and distant events. In some cases of hypomanic and even manic episodes, their ability to recall information can be extremely vivid and expanded. In extremes of depression and mania, they may experience difficulty in concentrating and focusing.

Physical health

Although the MSE has been used here to highlight key aspects of the examination, the clinician must pay particular attention to the patient’s physical health. As Fagiolini points out, patients with bipolar disorder have a high incidence of endocrine disorders, cardiovascular disorders, and obesity, and these factors must be considered when medications are prescribed.[39, 40]

Previous
Next

Complications

The main complications of bipolar disorder are suicide, homicide, and addictions.

Suicidal patients remain at risk for suicide. Patients emerging from a depression are thought to be at an increased risk for suicide. The risk of self-destructive behavior and death is lifelong. Hong’s 2003 study demonstrates a genetic link between bipolar disorder and suicidal behavior, especially in white individuals.[41] According to one study, men with bipolar disorder are at higher risk for suicide.[42]

The European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study, a 2-year prospective, observational study, suggests the following characteristics found in patients with bipolar disorder who are suicidal, may help identify subjects at risk for suicidal behavior:[43]

  • Female gender
  • A history of alcohol abuse
  • A history of substance abuse
  • Young age at first treatment for a mood episode
  • Longer disease duration
  • Greater depressive symptom severity (HAMD-5 total score)
  • Current benzodiazepine use
  • Higher overall symptom severity (CGI-BP: mania and overall score)
  • Poor compliance

Homicidal patients, often in the manic phase, can be very demanding and grandiose. In this context, they are angered if others do not immediately comply with their wishes. This can make them turn dramatically violent. In addition, they can become homicidal by acting on delusions.

Individuals with bipolar disorder are at risk for an addiction. This creates the problem of a dual diagnosis and, therefore, complicates treatment.

One area of major concern is the relationship between violent crime and bipolar disorder. This danger is particularly present and prominent with patients who have a substance abuse problem.[44] Although some persons with bipolar disorder may become violent, clinicians must be vigilant when treating patients with the dual diagnosis of substance abuse.

Quality of life (QOL) has been an important way to look at the effects of mental illness. BPI results in diminished quality of life as measured by health utility and QOL and utility-based health-related quality of life. The QOL losses in patients with BPI were less than those in persons with schizophrenia. The patients with depression sustained the greatest loss in QOL.[45]

In a study by Fiedorowicz et al, hypomania symptoms were frequently associated with progression to bipolar disorder, even when symptoms were low intensity; however, most patients did not have hypomania symptoms at baseline.[46] The study concluded that monitoring for progression to bipolar disorder is necessary in patients with long-term major depressive disorder.

Some of the most challenging situations involve children and adolescents with severe emotional lability. Often, psychiatrists have applied the bipolar diagnosis to this group. Leibenluft reviewed this situation and concluded that children have increasingly been diagnosed with bipolar disorder.[47] In some cases, the criteria were clearly met, whereas other cases were less clear.

Severe mood dysregulation is a syndrome formulated to describe the symptoms of children who do not clearly meet the criteria for bipolar disorder. Leibenluft’s findings revealed that nonepisodic irritability in youths is common and is associated with an elevated risk for anxiety and unipolar depressive disorders (not bipolar disorders) in adulthood. In fact, data suggest that children and adolescents with severe mood dysregulation have lower familiar rates of bipolar disorder than children and adolescents with bipolar disorder.

Previous
 
 
Contributor Information and Disclosures
Author

Stephen Soreff, MD  President of Education Initiatives, Nottingham, NH; Faculty, Metropolitan College of Boston University, Boston, MA

Stephen Soreff, MD is a member of the following medical societies: American College of Mental Health Administration and American Psychosomatic Society

Disclosure: Nothing to disclose.

Coauthor(s)

Lynne Alison McInnes, MD, MS  Associate Clinical Professor of Psychiatry, University of California, San Francisco, School of Medicine; Associate Adjunct Professor of Psychiatry and Genetics and Genomic Sciences, Department of Psychiatry and Human Genetics, Mount Sinai School of Medicine

Lynne Alison McInnes, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Psychiatric Association, and American Society of Human Genetics

Disclosure: Nothing to disclose.

Chief Editor

Iqbal Ahmed, MBBS, FRCPsych (UK)  Faculty, Department of Psychiatry, Tripler Army Medical Center; Clinical Professor of Psychiatry, Uniformed Services University of Health Sciences: Clinical Professor of Psychiatry, Clinical Professor of Geriatric Medicine, University of Hawaii, John A Burns School of Medicine

Iqbal Ahmed, MBBS, FRCPsych (UK) is a member of the following medical societies: Academy of Psychosomatic Medicine, American Association for Geriatric Psychiatry, American Neuropsychiatric Association, American Psychiatric Association, American Society of Clinical Psychopharmacology, and Royal College of Psychiatrists

Disclosure: Nothing to disclose.

Additional Contributors

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Bowden C, Singh V. Long-term Management of Bipolar Disorder. Available at http://www.medscape.com/viewprogram/2686. Accessed Dec 31, 2003.

  2. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry. Feb 2008;13(2):197-207. [Medline]. [Full Text].

  3. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. Jun 7 2007;447(7145):661-78. [Medline]. [Full Text].

  4. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. Jun 2008;13(6):558-69. [Medline].

  5. Ferreira MA, O'Donovan MC, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. Sep 2008;40(9):1056-8. [Medline]. [Full Text].

  6. McQuillin A, Rizig M, Gurling HM. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics. Aug 2007;17(8):605-17. [Medline].

  7. Sklar P, Ripke S, Scott LJ, et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. Sep 18 2011;43(10):977-83. [Medline].

  8. NIH News. Schizophrenia and Bipolar Disorder Share Genetic Roots. National Institutes of Health. Available at http://www.nih.gov/news/health/jul2009/nimh-01.htm. Accessed August 26, 2009.

  9. Post RM, Speer AM, Hough CJ, Xing G. Neurobiology of bipolar illness: implications for future study and therapeutics. Ann Clin Psychiatry. Jun 2003;15(2):85-94. [Medline].

  10. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A. Apr 10 2007;104(15):6406-11. [Medline]. [Full Text].

  11. Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime?. Trends Genet. Jun 2006;22(6):306-13. [Medline].

  12. American College of Neuropsychopharmacology. American College of Neuropsychopharmacology 2010 Annual Meeting Abstracts. December 5-9, 2010; Miami Beach, Florida.

  13. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry. Mar 2005;10(3):309-22. [Medline].

  14. Davis KL, Haroutunian V. Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. Sep 6 2003;362(9386):758. [Medline].

  15. Prabakaran S, Swatton JE, Ryan MM, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. Jul 2004;9(7):684-97, 643. [Medline].

  16. Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. Sep 6 2003;362(9386):798-805. [Medline].

  17. Adler CM, Holland SK, Schmithorst V, Wilke M, Weiss KL, Pan H, et al. Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord. Jun 2004;6(3):197-203. [Medline].

  18. Adler CM, Adams J, DelBello MP, et al. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. Am J Psychiatry. Feb 2006;163(2):322-4. [Medline].

  19. Houenou J, Frommberger J, Carde S, et al. Neuroimaging-based markers of bipolar disorder: Evidence from two meta-analyses. J Affect Disord. Aug 2011;132(3):344-55. [Medline].

  20. Chen G, Zeng WZ, Yuan PX, et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. Feb 1999;72(2):879-82. [Medline].

  21. Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons in bipolar disorder. Arch Gen Psychiatry. Apr 2011;68(4):340-50. [Medline].

  22. Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. Aug 2008;33(9):2300. [Medline].

  23. The HUGE Project; Research Program on Genes, Environment, and Health. Multi-Ethnic Genome Wide Association Study of Bipolar Disorder. Kaiser Permanente. Available at http://www.dor.kaiser.org/external/DORExternal/rpgeh/collaboration.aspx?ekmensel=194f64c3_47_52_btnlink). Accessed December, 2011.

  24. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry. Apr 2002;159(4):539-45. [Medline].

  25. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry. Sep 15 2000;48(6):531-8. [Medline].

  26. Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry. Dec 1 2007;62(11):1310-6. [Medline].

  27. Lepping P, Menkes DB. Abuse of dosulepin to induce mania. Addiction. Jul 2007;102(7):1166-7. [Medline].

  28. Barnett JH, Huang J, Perlis RH, et al. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. Aug 2011;41(8):1593-604. [Medline].

  29. Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry. Nov 2003;64(11):1284-92. [Medline].

  30. Calabrese JR. Overview of patient care issues and treatment in bipolar spectrum and bipolar II disorder. J Clin Psychiatry. Jun 2008;69(6):e18. [Medline].

  31. Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011;68(3):241-251.

  32. Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ. Sep 13 2011;343:d5422. [Medline].

  33. Dogan S, Sabanciogullari S. The effects of patient education in lithium therapy on quality of life and compliance. Arch Psychiatr Nurs. Dec 2003;17(6):270-5. [Medline].

  34. National Institute of Mental Health. A story of bipolar disorder (manic-depressive illness). Available at http://www.nimh.nih.gov/publicat/bipolstory03.cfm. Accessed Dec 30, 2003.

  35. Webb M. The Years of Silence Are Past: My Father's Life With Bipolar Disorder. Am J Psychiatry. Dec 1 2003;160(12):2257.

  36. Journal of Affective Disorders. Misdiagnosing bipolar disorder - Do clinicians show heuristic biases?. May 2011;130(3):405-12. [Medline].

  37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, DSM-IV-TR. Washington, DC: 2000.

  38. Frye MA. Diagnostic dilemmas and clinical correlates of mixed states in bipolar disorder. J Clin Psychiatry. May 2008;69(5):e13. [Medline].

  39. Fagiolini A. Medical monitoring in patients with bipolar disorder: a review of data. J Clin Psychiatry. Jun 2008;69(6):e16. [Medline].

  40. Keck PE Jr. Evaluating Treatment Decisions in Bipolar Depression. Available at http://www.medscape.com/viewprogram/2571. Accessed Dec 30, 2003.

  41. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology. 2003;48(4):186-9. [Medline].

  42. Ilgen MA, Bohnert AS, Ignacio RV, McCarthy JF, Valenstein MM, Kim HM, et al. Psychiatric diagnoses and risk of suicide in veterans. Arch Gen Psychiatry. Nov 2010;67(11):1152-8. [Medline].

  43. Bellivier F, Yon L, Luquiens A, et al. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM). Bipolar Disord. Jun 2011;13(4):377-386. [Medline].

  44. Fazel S, Lichtenstein P, Grann M, Goodwin GM, Långström N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry. Sep 2010;67(9):931-8. [Medline].

  45. Saarni SI, Viertiö S, Perälä J, Koskinen S, Lönnqvist J, Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry. Nov 2010;197:386-94. [Medline].

  46. Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry. Jan 2011;168(1):40-8. [Medline]. [Full Text].

  47. Leibenluft E. Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. Am J Psychiatry. Feb 2011;168(2):129-42. [Medline].

  48. Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. Dec 2003;160(12):2099-107. [Medline].

  49. McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, et al. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Curr Opin Psychiatry. Jul 2007;20(4):406-16. [Medline].

  50. Bradford DW, Kim MM, Braxton LE, Marx CE, Butterfield M, Elbogen EB. Access to medical care among persons with psychotic and major affective disorders. Psychiatr Serv. Aug 2008;59(8):847-52. [Medline].

  51. Bauer M, Alda M, Priller J, Young LT. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry. Nov 2003;36 Suppl 3:S250-4. [Medline].

  52. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. Feb 25 2012;379(9817):721-8. [Medline].

  53. Ansari A, Osser DN. The psychopharmacology algorithm project at the Harvard South Shore Program: an update on bipolar depression. Harv Rev Psychiatry. 2010;18(1):36-55. [Medline].

  54. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. Aug 2010;67(8):793-802. [Medline]. [Full Text].

  55. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry. Feb 2011;72(2):156-67. [Medline].

  56. Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry. Jul 2011;199:57-63. [Medline].

  57. Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. Jan 30 2010;375(9712):385-95. [Medline].

  58. Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord. Jun 2007;9(4):394-412. [Medline].

  59. Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. Aug 16 2011;[Medline].

  60. Swartz HA, Thase ME. Pharmacotherapy for the treatment of acute bipolar II depression: current evidence. J Clin Psychiatry. Mar 2011;72(3):356-66. [Medline].

  61. Hirschfeld RMA (Chair); Work Group on Bipolar Disorder. Practice Guideline for the Treatment of Patients With Bipolar Disorder, Second Edition. Review and Synthesis of Available Evidence. Somatic Treatments of Acute Manic and Mixed Episodes. American Psychiatric Association. Available at http://www.psychiatryonline.com/pracGuide/PracticePDFs/Bipolar2e_Inactivated_04-16-09.pdf accessed 4/14/2011. Accessed April 14, 2011.

  62. Hamrin V, Iennaco JD. Psychopharmacology of pediatric bipolar disorder. Expert Rev Neurother. Jul 2010;10(7):1053-88. [Medline].

  63. Gutman DA, Nemeroff C. Atypical Antipsychotics in Bipolar Disorder. Medscape. Available at http://www.medscape.com/viewarticle/554128. Accessed June 27, 2007.

  64. Brooks JO 3rd, Goldberg JF, Ketter TA, Miklowitz DJ, Calabrese JR, Bowden CL, et al. Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder. J Clin Psychiatry. Feb 2011;72(2):240-7. [Medline].

  65. Susan Jeffrey. FDA Warns of Aseptic Meningitis Risk With Lamotrigine. FDA Warns of Aseptic Meningitis Risk With Lamotrigine. Available at http://www.medscape.com/viewarticle/726845?src=ddd&uac=41752PN. Accessed August 12, 2010.

  66. Sarris J, Mischoulon D, Schweiter I. Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression. J Clin Psychiatry. 2011;Online ahead of print..

Previous
Next
 
Table. FDA-Approved Bipolar Treatment Regimens
Generic NameTrade NameManicMixedMaintenanceDepression
ValproateDepakoteX
Carbamazepine extended releaseEquetroXX
LamotrigineLamictalX
LithiumXX
AripiprazoleAbilifyXXX
ZiprasidoneGeodonXX
RisperidoneRisperdalXX
AsenapineSaphrisXX
QuetiapineSeroquelXX
ChlorpromazineThorazineX
OlanzapineZyprexaXXX
Olanzapine/fluoxetine combinationSymbyaxX
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.